Peter Trepp is the Founder, Chairman, and CEO of InnoPath Therapeutics, a cutting-edge biotech company dedicated to advancing oncology drug development. Currently, Peter is attending Harvard Medical School, where he is enrolled in a year-long executive education program tailored for life sciences executives. With a track record of over $1 billion in successful exits, Peter is a seasoned entrepreneur who has built, scaled, and led multiple technology companies to successful exits, consistently delivering exceptional enterprise valuations and strong returns for shareholders. Prior to establishing InnoPath Therapeutics, he served as CEO of FaceFirst, a global leader in facial recognition technology, where he spearheaded engagements with numerous Fortune 50 companies. In addition to his entrepreneurial endeavors, Peter is an accomplished author, recognized for his book, The New Rules of Consumer Privacy, which explores the delicate balance between privacy, security, and convenience for consumer-facing organizations. Peter holds a Bachelor's degree in Economics from UC Irvine and an MBA from the UCLA Anderson School of Management. He is actively involved in his alma mater's community, serving as an Ex-Officio Trustee on the UC Irvine Foundation and as Chairman of the Board of Councilors for the UCI School of Social Sciences.